. 2019 Jul 17;17(7):e05749. doi: 10.2903/j.efsa.2019.5749

Table B.1.

Summary table on specifications data for flavouring substances in FGE.70Rev1

Information included in the EU Union List Regulation No. (EU) 1334/2008 as amended	Most recent available specifications dataa	EFSA Comments
02.049 1184 2780 589 7786‐44‐9	Nona‐2,6‐dien‐1‐ol	b	Liquid C₉H₁₆O 140.23	Insoluble Soluble	196 – IR NMR 95% not less than 92% (2E,6Z), 3‐5% (2E,6E) < 3% (2Z,6Z) and (2Z,6E)	1.463–1.465 0.860–0.880
02.139 1189 3911 11748 18409‐21‐7	Deca‐2,4‐dien‐1‐ol	b	Liquid C₁₀H₁₈O 154.25	Insoluble Soluble	112 (13 hPa) – IR NMR MS 95% (sum of isomers) 92–95% (2E,4E); 2–5% (2E,4Z); 2–5% (2Z,4E); 0–2% (2Z,4Z)	1.485–1.495 0.861–0.871	The chemical name in the UL should be changed to deca‐(2E,4E)‐dien‐1‐ol, in accordance with the CAS nr and the most recent specifications on stereoisomeric composition (Documentation provided to EFSA nr.10)
02.153 1784 33467‐79‐7	Hepta‐2,4‐dien‐1‐ol	b	Liquid C₇H₁₂O 112.17	Freely soluble	80 (19 hPa) – MS 95% 90–98% (2E,4E); 2–10% (2E,4Z); 2–10% (2Z,4E); 0–2% (2Z,4Z)	1.487–1.493	The chemical name in the UL should be changed to Hepta‐(2E,4E)‐dien‐1‐ol, in accordance with the CAs nr and the most recent specifications on stereoisomeric composition (Documentation provided to EFSA nr.10)
02.162 1174 3922 111‐28‐4	Hexa‐2,4‐dien‐1‐ol	b	Solid C₆H₁₀O 98.16	Insoluble Soluble	– 24–33 IR NMR MS 95% 95% or greater (2E,4E), up to 5% of (2E,4Z), < 3% (2Z,4E) and (2Z,4Z)	– –
02.188 1183 3951 11802 62488‐56‐6	Nona‐2,4‐dien‐1‐ol	At least 92%; secondary component 3‐4% 2‐nonen‐1‐ol	Liquid C₉H₁₆O 140.23	Insoluble Soluble	85 (0.7 hPa) – IR NMR MS 92% SC: 3–4% 2‐nonen‐1‐ol	1.486–1.496 0.862–0.872
05.057 1175 3429 640 142‐83‐6	Hexa‐2(trans),4(trans)‐dienal	b	Liquid C₆H₈O 96.13	Slightly soluble Soluble	64 (20 hPa) – MS 97% SC:(2–5%) hexa‐(2E,4Z)‐dienal, (1%) hexa‐(2Z,4Z)‐ dienal, (1%) hexa‐(2Z,4E)‐dienal, (0.1%) 2,4‐ hexadecanoic acid)	1.538–1.543 0.896–0.902 (20°)
05.058 1186 3377 659 557‐48‐2	Nona‐2(trans),6(cis)‐dienal	At least 92%; secondary component 4‐7% (E,E)‐2,6‐nonadienal	Liquid C₉H₁₄O 138.21	Insoluble Soluble	94 – IR 92% SC: 4–7% (E,E)‐2,6‐nonadienal	1.470–1.475 0.850–0.870
05.064 1198 3638 685 13552‐96‐0	Trideca‐2(trans),4(cis),7(cis)‐trienal	At least 71%; secondary components 14% 4‐cis‐7‐cis‐tridecadienol; 6% 3‐cis‐7‐cis‐tridecadienol; 5% 2‐trans‐7‐ cis‐tridecadienal; 3% 2‐trans‐4‐trans‐7‐cis‐tridecatrienal	Liquid C₁₃H₂₀O 192.30	Insoluble Soluble	138 (0.4 hPa) – NMR MS 71% SC:14% (4Z,7Z)‐tridecadienol; 6% (3Z,7Z)‐tridecadienol; 5% (2E,7Z)‐tridecadienal; 3% (2E,4E,7Z)‐tridecatrienal	1.472–1.478 0.801–0.809
05.071 1185 3212 732 6750‐03‐4	Nona‐2,4‐dienal	At least 89%; secondary components 5‐6% 2,4‐nonadien‐1‐ol and 1‐2% 2‐nonen‐1‐ol	Liquid C₉H₁₄O 138.21	Insoluble Soluble	97 (13 hPa) – IR MS 89% 90–98% (2E,4E); 0.1–9% (2E,4Z); 0.1–9% (2Z,4E); 0–2% (2Z,4Z)	1.522–1.525 0.850–0.870
05.084 1179 3164 729 4313‐03‐5	Hepta‐2,4‐dienal	At least 92%; Secondary components 2‐4% (E,Z)‐2,4‐heptadienal and 2‐4% 2,4‐heptadienoic acid	Liquid C₇H₁₀O 110.16	Insoluble Soluble	84 (1 hPa) – IR MS 92% 92–100% (2E,4E); 0.1–7% (2E,4Z); 1–5% (2Z,4E); 0–2% (2Z,4Z)	1.478–1.480 0.822–0.828	The chemical name in the UL should be changed to Hepta‐(2E,4E)‐dienal, in accordance with the CAS nr and the most recent specifications on stereoisomeric composition (Documentation provided to EFSA nr.10)
05.101 1173 3217 11695 764‐40‐9	Penta‐2,4‐dienal	b	Liquid C₅H₆O 82.13	n.a. Soluble	60 (91 hPa) – NMR MS 95% (predominantly E,E)	1.525–1.532 0.801–0.809
05.108 1195 3422 10385 13162‐46‐4	Undeca‐2,4‐dienal	b	Liquid C₁₁H₁₈O 166.26	Insoluble Soluble	129 (17 hPa) – NMR MS 95% sum of isomers. Up to 95% (E,E) with (5‐10%) (E,Z)	1.500–1.505 0.896–0.906
05.111 1182 3466 10371 56767‐18‐1	Octa‐2(trans),6(trans)‐dienal	b	Liquid C₈H₁₂O 124.19	Insoluble Soluble	97‐99 (5 hPa) – IR NMR 96%	1.469–1.475 0.835–0.841
05.120 1197 3637 21662‐13‐5	Dodeca‐2,6‐dienal	b	Liquid C₁₂H₂₀O 180.28	Insoluble Soluble	130 (7 hPa) – NMR 97% > 95% (2E,6Z)‐Dodeca‐2,6‐dienal	1.425–1.431 0.987–0.993	The chemical name in the UL should be changed to Dodeca‐(2E,6Z)‐dienal, in accordance with the CAS nr and the most recent specifications on stereoisomeric composition (Documentation provided to EFSA nr.10)
05.125 1196 3670 11758 21662‐16‐8	Dodeca‐2,4‐dienal	At least 85%; secondary component 11–12% 2‐trans‐4‐cis isomer	Liquid C₁₂H₂₀O 180.28	Slightly soluble Soluble Miscible in oils	130 – IR NMR MS 85% 90–98% (2E,4E); 0.1–9% (2E,4Z); 0.1–9% (2Z,4E); 0–2% (2Z,4Z)	1.470–1.476 0.983–0.989	The chemical name in the UL should be changed to Dodeca‐(2E,4E)‐dienal, in accordance with the CAS nr and the most recent specifications on stereoisomeric composition (Documentation provided to EFSA nr.10)
05.127 1181 3721 11805 30361‐28‐5	Octa‐2(trans),4(trans)‐dienal	b	Liquid C₈H₁₂O 124.18	Insoluble Soluble	105–106 (10 hPa) – IR NMR MS 95% (90–98%) (E,E) with (0.1–8%) (E,Z)	1.519–1.525 0.832–0.839
05.140 1190 3135 2120 25152‐84‐5	Deca‐2(trans),4(trans)‐dienal	At least 89%, Secondary components (3‐4%) mixture of (2Z,4Z), (2Z,4E) and(2E,4Z) ‐decadienals; (3‐4%) acetone plus trace of isopropanol	Liquid C₁₀H₁₆O 152.24	Insoluble Soluble	104 – IR MS minimum 90% of the (E,E)‐isomer and min. 95% (sum of isomers); SC: 4–5% (2E,4Z); < 1% (2Z,4Z); < 0.5% (2Z,4E); < 0,1% 2,4‐decadienoic acid	1.512–1.517 0.866–0.876	The minimum purity assay should be updated to 90% minimum of the (E,E)‐isomer; 95% (sum of isomers), in accordance with the latest data provided (Documentation provided to EFSA nr: 5)
05.141 1786 4089 51325‐37‐2	Deca‐2,4,7‐trienal	b	Liquid C₁₀H₁₄O 150.22	Very slightly soluble Very soluble	233 – IR NMR MS 95% (81–83%) (6E,4E,7Z) (5–6%) (2E,4Z,7Z); (10–11%) (2E,4E,7E)	1.538–1.544 0.898–0.905
05.172 1187 3766 17587‐33‐6	Nona‐2(trans),6(trans)‐dienal	b	Liquid C₉H₁₄O 138.21	Insoluble Soluble	88 (14 hPa) – NMR 97%	1.439–1.445 0.856–0.864
05.173 1785 4187 57018‐53‐8	Nona‐2,4,6‐trienal	b	Liquid C₉H₁₂O 136.19	Freely soluble	194 – MS 95% (sum of isomers) > 95% (2E,4E,6E); < 5% other isomers; 0–1% (2Z,4Z,6Z)	1.550–1.556 0.867–0.873	The chemical name in the UL should be changed to Nona‐(2E,4E,6E)‐trienal, in accordance with the CAS nr and the most recent specifications on stereoisomeric composition (Documentation provided to EFSA nr.10)
08.085 1176 3921 110‐44‐1	(E,E)‐Hexa‐2,4‐dienoic acid	b	Solid C₆H₈O₂ 112.13	Slightly soluble Soluble	– 132–135 IR NMR 99%	– –	This flavouring substance is also called sorbic acid and corresponds to food additive (E‐200)
09.194 1178 2459 635 2396‐84‐1	Ethyl (E,E)‐hexa‐2,4‐dienoic acid	b	Liquid C₈H₁₂O₂ 140.18	Slightly soluble Soluble	195–196 – IR MS 98%	1.491–1.498 0.936–0.939
09.260 1192 3148 10574 3025‐30‐7	Ethyl (E,Z)‐deca‐2,4‐dienoate	b	Liquid C₁₂H₂₀O₂ 196.29	Insoluble	120 (9 hPa) – NMR 90% SC: (E,E)‐ethyl 2,4‐decadienoate	1.480–1.1486 0.917–0.920	The purity and content of the secondary components should be clarified
09.300 1177 3714 689‐89‐4	Methyl (E,E)‐hexa‐2,4‐dienoic acid	b	Liquid C₇H₁₀O₂ 126.16	Slightly soluble Soluble	180 – IR NMR 99%	1.501–1.505 0.933–0.938
09.371 1193 3832 10576 78417‐28‐4	Ethyl deca‐2,4,7‐trienoate	b	Liquid C₁₂H₁₈O₂ 194.28	Soluble Soluble	134 (18 hPa) – IR NMR 95% (Mixture of (Z)‐ and (E)‐isomer for all three C=C double bonds)	1.547–1.554 0.933–0.939	CAS nr in Union List does not specify stereoisomeric composition. Composition of stereoisomeric mixture to be specified
09.573 1780 10675 1516‐17‐2	Hexa‐2,4‐dienyl acetate	b	Liquid C₁₀H₂₀O₂ 140.18	Freely soluble	80 (20 hPa) – MS 95% (predominantly E,E‐isomer)	1.470–1.476 0.908–0.914
09.639 1191 3859 4493‐42‐9	Methyl (E,Z)‐deca‐2,4‐dienoate	At least 93%; secondary component 2–5% (E,E) methyl 2,4‐decadienoate	Liquid C₁₁H₁₈O₂ 182.26	Insoluble Soluble	67 (1 hPa) – IR NMR 93% (Material in commerce is min. 93% pure (2E,4Z)‐isomer. Min. Purity > 95% (sum of isomers: other isomer mainly (2E,4E)‐isomer)	1.488–1.494 0.917–0.923
09.840 1194 3648 10889 84788‐08‐9	Propyl 2,4‐decadienoate	b	Liquid C₁₃H₂₂O₂ 210.32	Insoluble Soluble	110 (0.5 hPa) – NMR 95% (Mixture of (Z)‐ and (E)‐isomer for two C = C‐double bonds)	1.468–1.475 0.913–0.919	Composition of the stereoisomeric mixture to be specified
09.947 1188 3952 68555‐65‐7	(E,Z)‐2,6‐Nonadienyl acetate	b	Liquid C₁₁H₁₈O₂ 182.26	Sparingly soluble Soluble	231 ‐ IR NMR MS 95%	1.448–1.458 0.905–0.907

Information included in the EU Union List Regulation No. (EU) 1334/2008 as amended

Most recent available specifications dataa

EFSA Comments

FL‐no JECFA‐no FEMA no CoE no CAS no

Chemical name

Purity of the named compound

Phys. form Mol. formula Mol. weight

Solubilityc Solubility in ethanold

Boiling point, °Ce Melting point, °C ID test Assay minimum isomers distribution/ SCh

Refrac. indexf Spec. gravityg

02.049

1184

2780

589

7786‐44‐9

Nona‐2,6‐dien‐1‐ol

Liquid

C₉H₁₆O

140.23

Insoluble

Soluble

196

–

IR NMR

95%

not less than 92% (2E,6Z),

3‐5% (2E,6E)

< 3% (2Z,6Z) and (2Z,6E)

1.463–1.465

0.860–0.880

02.139

1189

3911

11748

18409‐21‐7

Deca‐2,4‐dien‐1‐ol

Liquid

C₁₀H₁₈O

154.25

Insoluble

Soluble

112 (13 hPa)

–

IR NMR MS

95% (sum of isomers)

92–95% (2E,4E); 2–5% (2E,4Z); 2–5% (2Z,4E); 0–2% (2Z,4Z)

1.485–1.495

0.861–0.871

The chemical name in the UL should be changed to deca‐(2E,4E)‐dien‐1‐ol, in accordance with the CAS nr and the most recent specifications on stereoisomeric composition

(Documentation provided to EFSA nr.10)

02.153

1784

33467‐79‐7

Hepta‐2,4‐dien‐1‐ol

Liquid

C₇H₁₂O

112.17

Freely soluble

80 (19 hPa)

–

95%

90–98% (2E,4E); 2–10% (2E,4Z); 2–10% (2Z,4E); 0–2% (2Z,4Z)

1.487–1.493

The chemical name in the UL should be changed to Hepta‐(2E,4E)‐dien‐1‐ol, in accordance with the CAs nr and the most recent specifications on stereoisomeric composition (Documentation provided to EFSA nr.10)

02.162

1174

3922

111‐28‐4

Hexa‐2,4‐dien‐1‐ol

Solid

C₆H₁₀O

98.16

Insoluble

Soluble

–

24–33

IR NMR MS

95%

95% or greater (2E,4E),

up to 5% of (2E,4Z),

< 3% (2Z,4E) and (2Z,4Z)

–

02.188

1183

3951

11802

62488‐56‐6

Nona‐2,4‐dien‐1‐ol

At least 92%; secondary component

3‐4% 2‐nonen‐1‐ol

Liquid

C₉H₁₆O

140.23

Insoluble

Soluble

85 (0.7 hPa)

–

IR NMR MS

92%

SC: 3–4% 2‐nonen‐1‐ol

1.486–1.496

0.862–0.872

05.057

1175

3429

640

142‐83‐6

Hexa‐2(trans),4(trans)‐dienal

Liquid

C₆H₈O

96.13

Slightly soluble

Soluble

64 (20 hPa)

–

97%

SC:(2–5%) hexa‐(2E,4Z)‐dienal, (1%) hexa‐(2Z,4Z)‐ dienal, (1%) hexa‐(2Z,4E)‐dienal, (0.1%) 2,4‐ hexadecanoic acid)

1.538–1.543

0.896–0.902 (20°)

05.058

1186

3377

659

557‐48‐2

Nona‐2(trans),6(cis)‐dienal

At least 92%; secondary component

4‐7% (E,E)‐2,6‐nonadienal

Liquid

C₉H₁₄O

138.21

Insoluble

Soluble

–

92%

SC: 4–7% (E,E)‐2,6‐nonadienal

1.470–1.475

0.850–0.870

05.064

1198

3638

685

13552‐96‐0

Trideca‐2(trans),4(cis),7(cis)‐trienal

At least 71%; secondary components 14% 4‐cis‐7‐cis‐tridecadienol; 6% 3‐cis‐7‐cis‐tridecadienol; 5% 2‐trans‐7‐

cis‐tridecadienal; 3% 2‐trans‐4‐trans‐7‐cis‐tridecatrienal

Liquid

C₁₃H₂₀O

192.30

Insoluble

Soluble

138 (0.4 hPa)

–

NMR MS

71%

SC:14% (4Z,7Z)‐tridecadienol; 6% (3Z,7Z)‐tridecadienol; 5% (2E,7Z)‐tridecadienal; 3% (2E,4E,7Z)‐tridecatrienal

1.472–1.478

0.801–0.809

05.071

1185

3212

732

6750‐03‐4

Nona‐2,4‐dienal

At least 89%; secondary components 5‐6% 2,4‐nonadien‐1‐ol and 1‐2% 2‐nonen‐1‐ol

Liquid

C₉H₁₄O

138.21

Insoluble

Soluble

97 (13 hPa)

–

IR MS

89%

90–98% (2E,4E); 0.1–9% (2E,4Z); 0.1–9% (2Z,4E);

0–2% (2Z,4Z)

1.522–1.525

0.850–0.870

05.084

1179

3164

729

4313‐03‐5

Hepta‐2,4‐dienal

At least 92%;

Secondary components

2‐4% (E,Z)‐2,4‐heptadienal and 2‐4% 2,4‐heptadienoic acid

Liquid

C₇H₁₀O

110.16

Insoluble

Soluble

84 (1 hPa)

–

IR MS

92%

92–100% (2E,4E); 0.1–7%

(2E,4Z); 1–5% (2Z,4E); 0–2% (2Z,4Z)

1.478–1.480

0.822–0.828

The chemical name in the UL should be changed to Hepta‐(2E,4E)‐dienal, in accordance with the CAS nr and the most recent specifications on stereoisomeric composition (Documentation provided to EFSA nr.10)

05.101

1173

3217

11695

764‐40‐9

Penta‐2,4‐dienal

Liquid

C₅H₆O

82.13

n.a.

Soluble

60 (91 hPa)

–

NMR MS

95%

(predominantly E,E)

1.525–1.532

0.801–0.809

05.108

1195

3422

10385

13162‐46‐4

Undeca‐2,4‐dienal

Liquid

C₁₁H₁₈O

166.26

Insoluble

Soluble

129 (17 hPa)

–

NMR MS

95%

sum of isomers. Up to 95% (E,E) with (5‐10%) (E,Z)

1.500–1.505

0.896–0.906

05.111

1182

3466

10371

56767‐18‐1

Octa‐2(trans),6(trans)‐dienal

Liquid

C₈H₁₂O

124.19

Insoluble

Soluble

97‐99 (5 hPa)

–

IR NMR

96%

1.469–1.475

0.835–0.841

05.120

1197

3637

21662‐13‐5

Dodeca‐2,6‐dienal

Liquid

C₁₂H₂₀O

180.28

Insoluble

Soluble

130 (7 hPa)

–

NMR

97%

> 95% (2E,6Z)‐Dodeca‐2,6‐dienal

1.425–1.431

0.987–0.993

The chemical name in the UL should be changed to Dodeca‐(2E,6Z)‐dienal, in accordance with the CAS nr and the most recent specifications on stereoisomeric composition (Documentation provided to EFSA nr.10)

05.125

1196

3670

11758

21662‐16‐8

Dodeca‐2,4‐dienal

At least 85%; secondary component 11–12% 2‐trans‐4‐cis isomer

Liquid

C₁₂H₂₀O

180.28

Slightly soluble

Soluble

Miscible in oils

130

–

IR NMR MS

85%

90–98% (2E,4E); 0.1–9% (2E,4Z); 0.1–9% (2Z,4E); 0–2% (2Z,4Z)

1.470–1.476

0.983–0.989

The chemical name in the UL should be changed to Dodeca‐(2E,4E)‐dienal, in accordance with the CAS nr and the most recent specifications on stereoisomeric composition (Documentation provided to EFSA nr.10)

05.127

1181

3721

11805

30361‐28‐5

Octa‐2(trans),4(trans)‐dienal

Liquid

C₈H₁₂O

124.18

Insoluble

Soluble

105–106 (10 hPa)

–

IR NMR MS

95%

(90–98%) (E,E) with (0.1–8%) (E,Z)

1.519–1.525

0.832–0.839

05.140

1190

3135

2120

25152‐84‐5

Deca‐2(trans),4(trans)‐dienal

At least 89%, Secondary components (3‐4%) mixture of (2Z,4Z), (2Z,4E) and(2E,4Z) ‐decadienals; (3‐4%) acetone plus trace of isopropanol

Liquid

C₁₀H₁₆O

152.24

Insoluble

Soluble

104

–

IR MS

minimum 90% of the

(E,E)‐isomer and min. 95% (sum of isomers);

SC: 4–5% (2E,4Z); < 1% (2Z,4Z); < 0.5% (2Z,4E); < 0,1% 2,4‐decadienoic acid

1.512–1.517

0.866–0.876

The minimum purity assay should be updated to 90% minimum of the (E,E)‐isomer; 95% (sum of isomers), in accordance with the latest data provided (Documentation provided to EFSA nr: 5)

05.141

1786

4089

51325‐37‐2

Deca‐2,4,7‐trienal

Liquid

C₁₀H₁₄O

150.22

Very slightly soluble

Very soluble

233

–

IR NMR MS

95%

(81–83%) (6E,4E,7Z)

(5–6%) (2E,4Z,7Z);

(10–11%) (2E,4E,7E)

1.538–1.544

0.898–0.905

05.172

1187

3766

17587‐33‐6

Nona‐2(trans),6(trans)‐dienal

Liquid

C₉H₁₄O

138.21

Insoluble

Soluble

88 (14 hPa)

–

NMR

97%

1.439–1.445

0.856–0.864

05.173

1785

4187

57018‐53‐8

Nona‐2,4,6‐trienal

Liquid

C₉H₁₂O

136.19

Freely soluble

194

–

95% (sum of isomers)

> 95% (2E,4E,6E); < 5% other isomers; 0–1% (2Z,4Z,6Z)

1.550–1.556

0.867–0.873

The chemical name in the UL should be changed to Nona‐(2E,4E,6E)‐trienal, in accordance with the CAS nr and the most recent specifications on stereoisomeric composition (Documentation provided to EFSA nr.10)

08.085

1176

3921

110‐44‐1

(E,E)‐Hexa‐2,4‐dienoic acid

Solid

C₆H₈O₂

112.13

Slightly soluble

Soluble

–

132–135

IR NMR

99%

–

This flavouring substance is also called sorbic acid and corresponds to food additive (E‐200)

09.194

1178

2459

635

2396‐84‐1

Ethyl (E,E)‐hexa‐2,4‐dienoic acid

Liquid

C₈H₁₂O₂

140.18

Slightly soluble

Soluble

195–196

–

IR MS

98%

1.491–1.498

0.936–0.939

09.260

1192

3148

10574

3025‐30‐7

Ethyl (E,Z)‐deca‐2,4‐dienoate

Liquid

C₁₂H₂₀O₂

196.29

Insoluble

120 (9 hPa)

–

NMR

90%

SC: (E,E)‐ethyl 2,4‐decadienoate

1.480–1.1486

0.917–0.920

The purity and content of the secondary components should be clarified

09.300

1177

3714

689‐89‐4

Methyl (E,E)‐hexa‐2,4‐dienoic acid

Liquid

C₇H₁₀O₂

126.16

Slightly soluble

Soluble

180

–

IR NMR

99%

1.501–1.505

0.933–0.938

09.371

1193

3832

10576

78417‐28‐4

Ethyl deca‐2,4,7‐trienoate

Liquid

C₁₂H₁₈O₂

194.28

Soluble

134 (18 hPa)

–

IR NMR

95%

(Mixture of (Z)‐ and (E)‐isomer for all three C=C double bonds)

1.547–1.554

0.933–0.939

CAS nr in Union List does not specify stereoisomeric composition. Composition of stereoisomeric mixture to be specified

09.573

1780

10675

1516‐17‐2

Hexa‐2,4‐dienyl acetate

Liquid

C₁₀H₂₀O₂

140.18

Freely soluble

80 (20 hPa)

–

95%

(predominantly E,E‐isomer)

1.470–1.476

0.908–0.914

09.639

1191

3859

4493‐42‐9

Methyl (E,Z)‐deca‐2,4‐dienoate

At least 93%; secondary component

2–5% (E,E) methyl 2,4‐decadienoate

Liquid

C₁₁H₁₈O₂

182.26

Insoluble

Soluble

67 (1 hPa)

–

IR NMR

93%

(Material in commerce is min. 93% pure (2E,4Z)‐isomer. Min. Purity > 95% (sum of isomers: other isomer mainly (2E,4E)‐isomer)

1.488–1.494

0.917–0.923

09.840

1194

3648

10889

84788‐08‐9

Propyl 2,4‐decadienoate

Liquid

C₁₃H₂₂O₂

210.32

Insoluble

Soluble

110 (0.5 hPa)

–

NMR

95%

(Mixture of (Z)‐ and (E)‐isomer for two C = C‐double bonds)

1.468–1.475

0.913–0.919

Composition of the stereoisomeric mixture to be specified

09.947

1188

3952

68555‐65‐7

(E,Z)‐2,6‐Nonadienyl acetate

Liquid

C₁₁H₁₈O₂

182.26

Sparingly soluble

Soluble

231

‐

IR NMR MS

95%

1.448–1.458

0.905–0.907

FGE: Flavouring Group Evaluation; FL‐no: FLAVIS number; FLAVIS: Flavour Information System; JECFA: The Joint FAO/WHO Expert Committee on Food Additives; FEMA: Flavor and Extract Manufacturers Association; CoE: Council of Europe; CAS: Chemical Abstract Service; ID: identity; IR: infrared spectroscopy; NMR: nuclear magnetic resonance; MS: mass spectrometry.

JECFA (2003, 2007) and Documentation provided to EFSA nr.4;5;7;10 and 15.

At least 95% unless otherwise specified.

Solubility in water, if not otherwise stated.

Solubility in 95% ethanol, if not otherwise stated.

At 1013.25 hPa, if not otherwise stated.

At 20°C, if not otherwise stated.

At 25°C, if not otherwise stated.

SC: Secondary components.